TORONTO, Ontario and CAMBRIDGE, Massachusetts, April 07, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or…
Results from Planned Interim Analysis Expected First Quarter 2023 A Positive Outcome in RESILIENT Together with Results from Previous Positive…
WALTHAM, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-selective immuno-oncology therapies…
Topline efficacy and safety data expected in first half of 2023BRISBANE, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc.…
Orphazyme A/S in restructuringCompany announcementNo. 20/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, April 7, 2022 – Orphazyme A/S in restructuring…
Company announcement no. 5 - 227 April 2022 NTG Nordic Transport Group A/S - Annual General Meeting 2022 Today, at…
LETHBRIDGE, Alberta, April 07, 2022 (GLOBE NEWSWIRE) -- The fourth annual Green Shirt Day is led by the Boulet family…
LOS ANGELES, April 07, 2022 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., (NASDAQ: ENOB), a company focused on gene-modified cellular and…
At GN Store Nord’s annual general meeting on March 9, 2022, it was decided to authorize the board of directors…
MARTINSRIED / MUNICH, Germany, April 07, 2022 (GLOBE NEWSWIRE) -- iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics…